Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/866669/spago-nanomedical-receives-declarations-of-intent-from-the-largest-owner-board-and-management-team-regarding-the-exercise-of-to12
https://www.accesswire.com/865312/spago-nanomedical-provides-an-update-on-tumorad-01-trial-proceeds-as-planned
https://www.accesswire.com/864564/the-exercise-period-for-spago-nanomedicals-warrants-of-series-to12-commences-today
https://www.accesswire.com/864046/spago-nanomedical-publishes-the-annual-report-for-2023
https://www.accesswire.com/859823/notice-to-annual-general-meeting-of-spago-nanomedical-ab-publ
https://www.accesswire.com/858786/spago-nanomedical-interim-report-january-march-2024
https://www.accesswire.com/856028/spago-nanomedical-reports-favorable-data-in-breast-cancer-model-with-tumorad
https://www.accesswire.com/853454/spago-nanomedical-strengthens-management-with-head-of-cmc-supply